Nirmatrelvir-ritonavir, sold by Pfizer under the name Paxlovid, is commonly prescribed to treat COVID-19. When treating some heart patients, however, physicians may want to consider an alternative approach.

Reviewing data from more than 23.5 million U.S. patients, the study's authors found that methamphetamine use was linked to a whopping 86% increase in a patient's AFib risk. The other substances included in the analysis were not far behind. 

The hugely influential doctor will still serve as the general director of the Spanish National Center for Cardiovascular Research and editor-in-chief of the Journal of the American College of Cardiology.

Deepak Bhatt, MD, a professor of medicine at Harvard Medical School, details the new generation of cholesterol-lowering agents and their roles in patient care. 

Researchers explored data from nearly 20,000 patients, sharing their findings in Annals of Internal Medicine.

The solutions, Plaque Analysis and RoadMap Analysis, both use coronary CT angiography to provide clinicians with a noninvasive look at patients who present with coronary artery disease and face a heightened myocardial infarction risk.

Heart failure-related mortality among older adults improved from 1999 to 2012, but then things changed considerably over the next several years. Researchers explored the latest data at length, sharing their findings in JACC: Heart Failure.

Nodular patterns were the most commonly visualized abnormality, although several others were observed.

The adult brain may be more malleable than scientists previously thought, according to new research presented at the 35th European College of Neuropsychopharmacology.